Captopril
Captopril: Understanding its Impact, Recognizing Problems, and Ways to Improve
Captopril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and certain types of congestive heart failure. It was the first oral ACE inhibitor discovered for hypertension treatment.Unlike beta-blockers, Captopril does not cause fatigue. Its chemical structure is designated as 1-[(2S)-3-mercapto-2-methylpropionyl]-L-proline . It is a white to off-white crystalline powder, soluble in water, methanol, and ethanol.
Impact of Gene Variant
- Genetic factors can influence an individual’s response to Captopril. Variations in genes related to the renin-angiotensin-aldosterone system (RAAS) may affect drug efficacy and side effects.
- Polymorphisms in ACE and other related genes can impact Captopril metabolism and its effects on blood pressure regulation.
Ways to Recognize Problems
- Regular monitoring of blood pressure and renal function is crucial during Captopril therapy.
- Genetic testing can identify potential variations in genes associated with ACE activity and drug response.
